泊马度胺
小脑
沙利度胺
来那度胺
药理学
癌症研究
医学
免疫学
化学
多发性骨髓瘤
生物化学
泛素
基因
泛素连接酶
作者
Yohannes Gemechu,David Millrine,Shigeru Hashimoto,Jaya Prakash,Ksenia Sanchenkova,Hozaifa Metwally,Gyanu Parajuli,Sujin Kang,Tadamitsu Kishimoto
标识
DOI:10.1073/pnas.1814446115
摘要
mice but not in the WT group. We have also tested a thalidomide derivative, FPFT-2216, which showed an inhibitory effect toward IKZF1 protein level. As opposed to pomalidomide, FPFT-2216 and lenalidomide degrades CK-1α. Additionally, we assessed the potential therapeutic effects of IMiDs in dextran sodium sulfate (DSS)-induced colitis. In both WT and humanized mice, lenalidomide showed a significant therapeutic effect in the DSS model of colitis, while the effect of pomalidomide was less pronounced. Thus, while IMiDs' degradative effect on IKZF1 and CK-1α, and up-regulation of IL-2, is dependent on CRBN, the therapeutic benefit of IMiDs in a mouse model of inflammatory bowel disease occurs through a CRBN-IMiD binding region independent pathway.
科研通智能强力驱动
Strongly Powered by AbleSci AI